Verisk Analytics, Inc., Acquires Healix Risk Rating

Verisk Analytics, Inc. (Nasdaq:VRSK) announced the acquisition of Healix Risk Rating, a leader in automated medical risk assessment for the travel insurance industry. Healix Risk Rating, a subsidiary of Healix International Holdings Limited based in Surrey, United Kingdom, will become part of ISO, a Verisk Analytics business and a leading source of information about property/casualty insurance risk for more than 45 years.

The acquisition will further expand Verisk’s risk assessment offerings for the global insurance industry, providing solutions that are embedded with customer workflows and can help underwrite medical coverage for travelers with greater speed, accuracy, and efficiency.

“Travel insurance is part of the global property/casualty insurance market and a line of business where underwriters often need to quickly evaluate and price risks that can vary widely depending on those traveling and where they’re visiting,” said Beth Fitzgerald, president of ISO Solutions. “The powerful tools developed by Healix Risk Rating allow insurers to identify and assess these risks at point of sale and allow us to better serve both the travel insurance market and property/casualty insurers around the world.”

“We’re proud to join Verisk, whose access to a global network, vast industry knowledge, and experience with analytics will help us enhance our products and provide additional value to our clients,” said Paul Beven, managing director, Global, and founder of Healix Risk Rating.

“Healix Risk Rating and its unique underwriting tools will be a valuable addition to Verisk Analytics as we develop new ways to innovate with our customers around the world,” said Mark Anquillare, executive vice president and chief operating officer of Verisk Analytics.

About Healix Risk Rating: Healix Risk Rating is located in Surrey, United Kingdom. It was founded in 2000 as a wholly owned subsidiary of Healix International Holdings Limited. Healix Risk Rating has an unrivaled reputation as a market-leading provider of automated medical risk assessment in the travel insurance market.